Bio-T-Gel, a testosterone gel manufactured by Teva Pharmaceuticals, may be associated with an increased risk of serious cardiovascular complications, including heart attacks and strokes. Thousands of testosterone lawsuits are now being pursued on behalf of men who allegedly suffered these life-threatening events due to their use of low-T therapy medications.
Men who experienced a heart attack, stroke, pulmonary embolism or deep vein thrombosis while using Bio-T-Gel may be entitled to compensation for their injury-related damages. To learn if you are eligible to file a Bio-T-Gel lawsuit, please call (888) 994-5118 to discuss your case with an attorney at Bernstein Liebhard LLP.
Bio-T-Gel is a testosterone gel approved by the U.S. Food & Drug Administration (FDA) in 2012. It is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone, specifically primary hypogonadism (and hypogonadotropic hypogonadism. It is not approved, and has never been proven safe and effective, for the treatment of age-related testosterone deficiency.
A growing body of evidence has indicated that the use of low-T therapy, such as Bio-T-Gel, may increase the risk that certain men will experience a heart attack, stroke or other cardiovascular complications:
The FDA has also issued safety alerts regarding testosterone treatments and cardiovascular side effects:
You may be eligible to file a Bio-T-Gel lawsuit if you suffered a heart attack, stroke or dangerous blood clot while using this low-T treatment. To learn more about the growing testosterone litigation, please call (888) 994-5118.
Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.